David Christopher Hayward
Directeur Général chez Micropore Technologies Ltd.
Profil
David Christopher Hayward is currently the Chief Executive Officer of Micropore Technologies Ltd.
He previously held the position of Chief Executive Officer at CellAura Technologies Ltd.
and Chief Executive Officer & Director at Q-Flo Ltd.
Postes actifs de David Christopher Hayward
| Sociétés | Poste | Début |
|---|---|---|
Micropore Technologies Ltd.
 Micropore Technologies Ltd. BiotechnologyHealth Technology Micropore Technologies Ltd. develops and manufactures membrane emulsification technologies and chemicals. The firm offers entry level dispersion cells, laboratory scale torsional systems, laboratory scale crossflow systems, pilot and production scale torsional systems, and pilot and production scale crossflow systems; and consultancy services. Its products are used in pharmaceuticals, food and beverages, chromatography, inks, nutraceuticals, specialist particles and emulsions, agrochemical, veterinarian and animal feed, and insect repellents, as well as cosmetics, fragrances, and skincare applications. The company was founded by Richard Holdich in 2003 and is headquartered in Redcar, the United Kingdom. | Directeur Général | 01/01/2010 |
Anciens postes connus de David Christopher Hayward
| Sociétés | Poste | Fin |
|---|---|---|
Q-Flo Ltd.
 Q-Flo Ltd. Miscellaneous Commercial ServicesCommercial Services Q-Flo Ltd. provides research in the areas of advanced nano-enabled materials. It produces long carbon nanotube fibre and mats is patent protected and operates as a single stage continuous process. The company was founded by Alan Windle and Martin Pick in 2004 and is headquartered in Nottingham, the United Kingdom. | Directeur Général | - |
CellAura Technologies Ltd.
 CellAura Technologies Ltd. Pharmaceuticals: MajorHealth Technology CellAura Technologies Ltd. offers drug discovery services. It combines world-renowned expertise in synthetic chemistry and molecular pharmacology to produce fluorescent reagents as tracers for G-protein coupled receptors (GPCRs) and other common drug discovery target classes. The company was founded by Barrie Kellam, Stephen J. Hill and George Michael in 2003 and is headquartered in Nottingham, the United Kingdom. | Directeur Général | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
CellAura Technologies Ltd.
CellAura Technologies Ltd. Pharmaceuticals: MajorHealth Technology CellAura Technologies Ltd. offers drug discovery services. It combines world-renowned expertise in synthetic chemistry and molecular pharmacology to produce fluorescent reagents as tracers for G-protein coupled receptors (GPCRs) and other common drug discovery target classes. The company was founded by Barrie Kellam, Stephen J. Hill and George Michael in 2003 and is headquartered in Nottingham, the United Kingdom. | Health Technology |
Q-Flo Ltd.
Q-Flo Ltd. Miscellaneous Commercial ServicesCommercial Services Q-Flo Ltd. provides research in the areas of advanced nano-enabled materials. It produces long carbon nanotube fibre and mats is patent protected and operates as a single stage continuous process. The company was founded by Alan Windle and Martin Pick in 2004 and is headquartered in Nottingham, the United Kingdom. | Commercial Services |
Micropore Technologies Ltd.
Micropore Technologies Ltd. BiotechnologyHealth Technology Micropore Technologies Ltd. develops and manufactures membrane emulsification technologies and chemicals. The firm offers entry level dispersion cells, laboratory scale torsional systems, laboratory scale crossflow systems, pilot and production scale torsional systems, and pilot and production scale crossflow systems; and consultancy services. Its products are used in pharmaceuticals, food and beverages, chromatography, inks, nutraceuticals, specialist particles and emulsions, agrochemical, veterinarian and animal feed, and insect repellents, as well as cosmetics, fragrances, and skincare applications. The company was founded by Richard Holdich in 2003 and is headquartered in Redcar, the United Kingdom. | Health Technology |
